bmiMD vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats bmiMD overall, scoring 8.2/10 vs 8/10. Willow is more affordable at $299/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Willow for users who want a balance of quality care and reasonable pric.
A side-by-side comparison of bmiMD and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
bmiMD
#9 of 40Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDWillow
#8 of 40Personalized GLP-1 weight loss with ongoing clinical support. The highest verified conversion rate among comprehensive care platforms.
Visit Willow| Feature | bmiMD | Willow |
|---|---|---|
| Our Score | 8/10 | 8.2/10 |
| Starting Price | $319/mo | $299/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Budget-first users who want affordable GLP-1 access | Users who want a balance of quality care and reasonable pricing |
| Ranking | #9 | #8 |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
- −$29.99 shipping fee per order — most competitors include free shipping
- −$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Switch between brand-name and compounded mid-treatment without restarting
- +$160/mo all-in — no consultation fees, no shipping charges, no lab surcharges
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out bmiMD with a score of 8.2/10 vs 8/10. If budget is your priority, Willow starts at $299/mo compared to bmiMD's $319/mo. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Willow if you want: users who want a balance of quality care and reasonable pricing.